A novel long non-coding RNA, PICSAR, promotes thyroid cancer progression through the hsa-miR-320A/hsa-miR-485/RAPGEFL1 axis.

IF 3.5 4区 医学 Q2 ONCOLOGY
Maryam Hejazi, Tahmineh Jafari, AmirHossein Yari, Ramin Heshmat, Bagher Larijani, Samaneh Ahvaz, Omid Pourbagherian, Seyed Mohammad Tavangar, Gita Shafiee, Amir Ali Mokhtarzadeh
{"title":"A novel long non-coding RNA, PICSAR, promotes thyroid cancer progression through the hsa-miR-320A/hsa-miR-485/RAPGEFL1 axis.","authors":"Maryam Hejazi, Tahmineh Jafari, AmirHossein Yari, Ramin Heshmat, Bagher Larijani, Samaneh Ahvaz, Omid Pourbagherian, Seyed Mohammad Tavangar, Gita Shafiee, Amir Ali Mokhtarzadeh","doi":"10.1007/s12032-025-02987-9","DOIUrl":null,"url":null,"abstract":"<p><p>Among endocrine cancers, thyroid carcinoma (TC) is the most prevalent and ranks sixth in global mortality rates. Aberrant expression of long non-coding RNA (lncRNAs) is associated with the progression of various human cancers, including TC. The role of PICSAR lncRNA (LINC00162) has been validated in different human cancers. Therefore, this study aimed to assess the expression levels and functions of lncRNA PICSAR in thyroid cancer tumorigenesis. This comprehensive approach combined in silico and in vitro methods to explore the molecular mechanisms and clinical significance of PICSAR in thyroid cancer. This work assessed the expression of the long non-coding RNA LINC00162 and identified differentially expressed genes (DEGs) using the Cancer Genome Atlas (TCGA) database. Interactions among LINC00162, hsa-miR-320A, hsa-miR-485, and RAPGEFL1 were investigated using the LncACT and miRDB databases. Bioinformatics techniques were employed to conduct functional enrichment analysis to clarify the relevant molecular pathways. For the investigation of LINC00162 expression in TC samples, 50 matched samples of thyroid carcinoma and adjacent normal tissue were gathered. Real time PCR was used to objectively evaluate the expression levels of the targeted genes. Every tissue sample was examined pathologically. A specific siRNA was transfected into a thyroid cancer cell line to examine the functional role of LINC00162. The impact of LINC00162 silencing was then assessed by measuring the level of target genes expression following the transfection. Based on TCGA-THCA analysis and qRT-PCR on tissue samples, LINC00162 (PICSAR) was markedly overexpressed in thyroid cancer tissues compared to normal samples. However, no discernible correlation was found between LINC00162 expression and the pathological characteristics of thyroid cancer. Our bioinformatics predictions based on lncRNA-microRNA interactions demonstrate that LINC00162 acts as a molecular sponge for the downregulated microRNAs hsa-miR-320A and hsa-miR-485 in thyroid cancer. RAPGEFL1, a gene associated with the development of thyroid cancer, is upregulated in conjunction with this downregulation. The LINC00162-miRNA-RAPGEFL1 axis is involved in critical carcinogenic processes, including thiamine metabolism, cell cycle control, and folate biosynthesis, according to functional enrichment analysis. Additionally, a bioinformatics study revealed a negative association between PICSAR and the NUDT3 gene, while a positive correlation was found with the SNX18P14 gene. Thyroid cancer cells transfected with LINC00162-specific siRNA showed significant downregulation of LINC00162 and RAPGEFL1, alongside an increase in hsa-miR-320A and hsa-miR-485, ultimately inhibiting the growth of thyroid cancer. These findings suggest that targeting PICSAR may offer a treatment strategy for thyroid cancer by altering important biological processes. In conclusion, LINC00162, which is overexpressed in thyroid cancer, acts as a molecular sponge for hsa-miR-320A and hsa-miR-485, regulating key oncogenic pathways and leading to the upregulation of RAPGEFL1. These effects are reversed upon siRNA-mediated silencing of LINC00162, indicating its potential as a promising therapeutic target for thyroid cancer. RAPGEFL1 regulates the Rap signaling pathway, controlling adhesion, migration, polarity, and metabolism to maintain cellular and tissue homeostasis. Its dysregulation is linked to various diseases, highlighting its potential as a therapeutic target.</p>","PeriodicalId":18433,"journal":{"name":"Medical Oncology","volume":"42 10","pages":"448"},"PeriodicalIF":3.5000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12032-025-02987-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Among endocrine cancers, thyroid carcinoma (TC) is the most prevalent and ranks sixth in global mortality rates. Aberrant expression of long non-coding RNA (lncRNAs) is associated with the progression of various human cancers, including TC. The role of PICSAR lncRNA (LINC00162) has been validated in different human cancers. Therefore, this study aimed to assess the expression levels and functions of lncRNA PICSAR in thyroid cancer tumorigenesis. This comprehensive approach combined in silico and in vitro methods to explore the molecular mechanisms and clinical significance of PICSAR in thyroid cancer. This work assessed the expression of the long non-coding RNA LINC00162 and identified differentially expressed genes (DEGs) using the Cancer Genome Atlas (TCGA) database. Interactions among LINC00162, hsa-miR-320A, hsa-miR-485, and RAPGEFL1 were investigated using the LncACT and miRDB databases. Bioinformatics techniques were employed to conduct functional enrichment analysis to clarify the relevant molecular pathways. For the investigation of LINC00162 expression in TC samples, 50 matched samples of thyroid carcinoma and adjacent normal tissue were gathered. Real time PCR was used to objectively evaluate the expression levels of the targeted genes. Every tissue sample was examined pathologically. A specific siRNA was transfected into a thyroid cancer cell line to examine the functional role of LINC00162. The impact of LINC00162 silencing was then assessed by measuring the level of target genes expression following the transfection. Based on TCGA-THCA analysis and qRT-PCR on tissue samples, LINC00162 (PICSAR) was markedly overexpressed in thyroid cancer tissues compared to normal samples. However, no discernible correlation was found between LINC00162 expression and the pathological characteristics of thyroid cancer. Our bioinformatics predictions based on lncRNA-microRNA interactions demonstrate that LINC00162 acts as a molecular sponge for the downregulated microRNAs hsa-miR-320A and hsa-miR-485 in thyroid cancer. RAPGEFL1, a gene associated with the development of thyroid cancer, is upregulated in conjunction with this downregulation. The LINC00162-miRNA-RAPGEFL1 axis is involved in critical carcinogenic processes, including thiamine metabolism, cell cycle control, and folate biosynthesis, according to functional enrichment analysis. Additionally, a bioinformatics study revealed a negative association between PICSAR and the NUDT3 gene, while a positive correlation was found with the SNX18P14 gene. Thyroid cancer cells transfected with LINC00162-specific siRNA showed significant downregulation of LINC00162 and RAPGEFL1, alongside an increase in hsa-miR-320A and hsa-miR-485, ultimately inhibiting the growth of thyroid cancer. These findings suggest that targeting PICSAR may offer a treatment strategy for thyroid cancer by altering important biological processes. In conclusion, LINC00162, which is overexpressed in thyroid cancer, acts as a molecular sponge for hsa-miR-320A and hsa-miR-485, regulating key oncogenic pathways and leading to the upregulation of RAPGEFL1. These effects are reversed upon siRNA-mediated silencing of LINC00162, indicating its potential as a promising therapeutic target for thyroid cancer. RAPGEFL1 regulates the Rap signaling pathway, controlling adhesion, migration, polarity, and metabolism to maintain cellular and tissue homeostasis. Its dysregulation is linked to various diseases, highlighting its potential as a therapeutic target.

一种新的长链非编码RNA PICSAR通过hsa-miR-320A/hsa-miR-485/RAPGEFL1轴促进甲状腺癌的进展。
在内分泌癌中,甲状腺癌(TC)最为普遍,在全球死亡率中排名第六。长链非编码RNA (lncRNAs)的异常表达与包括TC在内的各种人类癌症的进展有关。PICSAR lncRNA (LINC00162)的作用已在不同的人类癌症中得到验证。因此,本研究旨在评估lncRNA PICSAR在甲状腺癌肿瘤发生中的表达水平和功能。本综合方法结合计算机和体外方法,探讨PICSAR在甲状腺癌中的分子机制和临床意义。本研究评估了长链非编码RNA LINC00162的表达,并利用癌症基因组图谱(TCGA)数据库鉴定了差异表达基因(DEGs)。使用lnact和miRDB数据库研究了LINC00162、hsa-miR-320A、hsa-miR-485和RAPGEFL1之间的相互作用。利用生物信息学技术进行功能富集分析,明确相关分子途径。为了研究LINC00162在TC样本中的表达,我们收集了50例匹配的甲状腺癌和邻近正常组织样本。采用Real time PCR客观评价目标基因的表达水平。每个组织样本都进行了病理检查。将特异性siRNA转染到甲状腺癌细胞系中,以检测LINC00162的功能作用。然后通过测量转染后靶基因的表达水平来评估LINC00162沉默的影响。组织样本的TCGA-THCA分析和qRT-PCR结果显示,与正常样本相比,LINC00162 (PICSAR)在甲状腺癌组织中明显过表达。然而,没有发现LINC00162的表达与甲状腺癌的病理特征有明显的相关性。我们基于lncRNA-microRNA相互作用的生物信息学预测表明,LINC00162在甲状腺癌中作为下调的microrna hsa-miR-320A和hsa-miR-485的分子海绵。RAPGEFL1是一种与甲状腺癌发展相关的基因,其上调与下调同时发生。根据功能富集分析,LINC00162-miRNA-RAPGEFL1轴参与关键的致癌过程,包括硫胺素代谢、细胞周期控制和叶酸生物合成。此外,一项生物信息学研究发现PICSAR与NUDT3基因呈负相关,而与SNX18P14基因呈正相关。转染了LINC00162特异性siRNA的甲状腺癌细胞显示出LINC00162和RAPGEFL1的显著下调,hsa-miR-320A和hsa-miR-485的升高,最终抑制了甲状腺癌的生长。这些发现表明,靶向PICSAR可能通过改变重要的生物学过程为甲状腺癌提供一种治疗策略。综上所述,在甲状腺癌中过表达的LINC00162作为hsa-miR-320A和hsa-miR-485的分子海绵,调控关键的致癌通路,导致RAPGEFL1上调。这些作用在sirna介导的LINC00162沉默后被逆转,表明其作为甲状腺癌有希望的治疗靶点的潜力。RAPGEFL1调节Rap信号通路,控制粘附、迁移、极性和代谢,以维持细胞和组织的稳态。它的失调与多种疾病有关,突出了它作为治疗靶点的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Oncology
Medical Oncology 医学-肿瘤学
CiteScore
4.20
自引率
2.90%
发文量
259
审稿时长
1.4 months
期刊介绍: Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信